Pharmaceutical companies

Clinical pipeline of new antibiotics remains small, global report highlights

A quarter of clinical-stage antibiotics are supported by plans to ensure better access and good stewardship after launch compared to 7% in 2018, but the clinical pipeline of antibiotics for priority infections remains small, according to a report published by the Access to M…

Assessing environmental impact of medicines financially ‘catastrophic’ for pharmaceutical industry

Assessing the environmental risks of a new medicine as part of the risk-benefit assessment during market authorisation would be “catastrophic” for the pharmaceutical industry, an environmental scientist from manufacturer AstraZeneca has said.…

NHS trials new payment system to encourage development of new antibiotics

A subscription-style payment system is to be trialled by the NHS to help encourage the development of new antibiotics, the health secretary has announced.…

Government cap on branded medicine prices may be unsustainable, warns ABPI

An ongoing cap on the price of branded medicines to the NHS “may not be sustainable” in the long term, the Association of the British Pharmaceutical Industry has said.…

Government voices concerns about using legal powers for affordable access to cystic fibrosis drug

The government has said that using its legal power to “break the monopoly” held by drug company Vertex Pharmaceuticals over its combination cystic fibrosis treatment Orkambi would not represent “a quick solution”.ent Orkambi.…

Drugs companies asked to maintain a six-week stockpile for six months in the event of ‘no-deal’ Brexit

Pharmaceutical companies have been asked to maintain a rolling six-week stockpile of medicines for six months in the event of a ‘no-deal’ Brexit, the government has confirmed.…

Pharmaceutical company charged following investigation into deaths of babies

A pharmaceutical firm has been charged with criminal offences following a police investigation into the deaths and illnesses of babies at hospitals in England.…

Almost 1,500 pharma firms could miss FMD deadline, warns body in charge

Around 1,500 pharmaceutical companies are at risk of failure to comply with the Falsified Medicines Directive because they have yet to start working with the European Medicines Verification Organisation, the body has warned.…

Exclusive deal for Boots as sildenafil becomes P medicine

Boots UK strikes two-week deal with Pfizer to exclusively sell sildenafil over the counter after its reclassification from a prescription-only medicine to a pharmacy medicine.…

Dealing with medicines misuse in execution by lethal injection

New standards of industry best practice have been established for implementing distribution controls on drugs that could be used for execution…